These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38353497)

  • 1. Design of novel isoxazole derivatives as tubulin inhibitors using computer-aided techniques: QSAR modeling,
    Moukhliss Y; Koubi Y; Zafar I; Alaqarbeh M; Maghat H; Sbai A; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2024 Feb; ():1-12. PubMed ID: 38353497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies.
    Ortiz CLD; Completo GC; Nacario RC; Nellas RB
    Sci Rep; 2019 Nov; 9(1):17096. PubMed ID: 31745103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 1,3,4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach.
    Das A; Sarangi M; Jangid K; Kumar V; Kumar A; Singh PP; Kaur K; Kumar V; Chakraborty S; Jaitak V
    J Biomol Struct Dyn; 2023 Sep; ():1-19. PubMed ID: 37695635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-combined QSAR, molecular docking, molecular dynamics simulation, and ADMET of Flavonoid derivatives as potent cholinesterase inhibitors.
    Soufi H; Moussaoui M; Baammi S; Baassi M; Salah M; Daoud R; El Allali A; Belghiti ME; Moutaabbid M; Belaaouad S
    J Biomol Struct Dyn; 2024 Aug; 42(12):6027-6041. PubMed ID: 37485860
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling.
    Kumar A; Rai S; Rathi E; Agarwal P; Kini SG
    J Biomol Struct Dyn; 2021 Mar; 39(4):1155-1173. PubMed ID: 32037974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations.
    Daoui O; Nour H; Abchir O; Elkhattabi S; Bakhouch M; Chtita S
    J Biomol Struct Dyn; 2023; 41(16):7768-7785. PubMed ID: 36120976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
    Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
    Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation.
    Er-Rajy M; El Fadili M; Mujwar S; Zarougui S; Elhallaoui M
    J Biomol Struct Dyn; 2023; 41(21):11657-11670. PubMed ID: 36695085
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential
    Matos IA; Goes Pinto AC; Ferraz MVF; Adan WCS; Rodrigues RP; Dos Santos JX; Kitagawa RR; Lins RD; Oliveira TB; Costa Junior NBD
    J Biomol Struct Dyn; 2023 Jun; 41(9):3835-3846. PubMed ID: 35356863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined
    Guendouzi A; Belkhiri L; Guendouzi A; Derouiche TMT; Djekoun A
    J Biomol Struct Dyn; 2024; 42(1):119-133. PubMed ID: 36995063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
    El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico research on new sulfonamide derivatives as BRD4 inhibitors targeting acute myeloid leukemia using various computational techniques including 3D-QSAR, HQSAR, molecular docking, ADME/Tox, and molecular dynamics.
    Belghalia E; Ouabane M; El Bahi S; Rehman HM; Sbai A; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9201-9219. PubMed ID: 37656159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.
    Yu CX; Tan JW; Rullah K; Imran S; Tham CL
    J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
    Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
    Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.